Fresh off a $17 million Series A round, Qnovia is looking to bring a smoking cessation medical device to market in 2025.
Health care executive Mario Danek founded the company in 2018. The goal is to develop and market RespiRx, a hand-held aerosol device that delivers nicotine quickly, helping people quit smoking.
In 2020, Brian Quigley, the former CEO of Altria Group’s smokeless division, joined the company as COO. He was named CEO in August, and Danek moved over to chief technology officer.…
